Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Recruiting × stenoparib × Clear all

Phase

Phase 2 1 Phase 1/2 1

Status

Withdrawn 1 Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Small Cell Lung Carcinoma 1

Interventions

pembrolizumab 96 Cyclophosphamide 72 Carboplatin 55 fludarabine 52 Injections 52 Bevacizumab 44 Gemcitabine 38 venetoclax 35 Paclitaxel 34 Nivolumab 34 Dexamethasone 34 Cisplatin 34 Specimen Handling 33 Magnetic Resonance Spectroscopy 31 Docetaxel 30 Biopsy 29 Temozolomide 25 atezolizumab 23 Irinotecan 23 toripalimab 22 Pemetrexed 22 Capecitabine 21 Azacitidine 21 abemaciclib 20 Rituximab 20 Oxaliplatin 20 Fulvestrant 20 Radiotherapy 19 Fluorouracil 19 130-nm albumin-bound paclitaxel 18

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06681220 2026-03-11

Relapsed SCLC

VA Office of Research and Development

Phase 1/2 Recruiting

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡